BriaCell Therapeutics Corp.
BriaCell - Model Bria-IMT -Immunotherapy
Bria-IMT™ (developed from a breast cancer cell line) is a patented (USPTO) immunotherapy approach that directly stimulates the body’s own cancer fighting cells to attack and destroy breast cancer tumors.
Most popular related searches
immune system
breast cancer
cancer cell
cancerous tumor
T-cell
immunotherapy
cancer antigen
breast tumor
immune stimulating
immune activating
Induces an antitumor response both indirectly (i.e., by providing the tumor antigens for the immune system to recognize) and directly by stimulating the immune system (i.e., further activating T-cells), which collectively boosts the body’s response.